Trulieve Cannabis Corp
Ticker - TCNNF

One of the best ways to beat the crowd is by scanning for filings before they become circulated press.  This week, several OTC companies have filed impactful reports that should effect the markets.  Rogue One, Inc. ROAG filed an amended Q-2 2021 Quarterly financial statement on Tuesday which is the Company’s first consolidated quarterly that

Shares of Trulieve Cannabis Corp. (OTCMKTS:TCNNF – Get Rating) have been given an average rating of “Buy” by the nine analysts that are presently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued a report on the

The Daily Hit is a recap of cannabis business news for August 10, 2022. ON THE SITE Trulieve Reports Rising Revenue, But Gives Cautious Outlook Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) delivered its results for the quarter ending June 30, 2022, with revenue increasing 49% year over year to $320.3 million from $215.1 million

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our feedback forum. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. Read More

Trulieve Cannabis Corp. TRUL, +0.42% TCNNF, +0.38% said Wednesday it had a net loss of $1.1 million in the second quarter, or 12 cents a share, after earnings of $47 million, or 31 cents a share, in the year-earlier period. The Tallahassee, Fla.-based cannabis company said its adjusted per-share loss came to 1 cent, matching

Read More